LIXTE Biotechnology (NASDAQ: LIXT) Strengthens Oncology Pipeline Through Expanded LB-100 Clinical Trials
Austin, Texas, United States, March 31st, 2026, FinanceWire Researchers are increasingly focused on combination therapies and novel mechanisms of action […]









